Copenhagen, Denmark

Lauge Schaffer

USPTO Granted Patents = 3 


Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 61(Granted Patents)


Location History:

  • Copenhagen, DK (2002 - 2008)
  • Lyngby, DK (2013)

Company Filing History:


Years Active: 2002-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lauge Schaffer: Innovator in GLP-1 Compounds and Insulin Derivatives

Introduction

Lauge Schaffer is a prominent inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative compounds that enhance therapeutic outcomes for patients.

Latest Patents

Lauge Schaffer holds 3 patents that showcase his expertise in the area of glucose-dependent therapies. His latest patents include "Extended GLP-1 Compounds," which relates to protracted GLP-1 compounds and their therapeutic uses. Another notable patent is "Glucose Dependent Release of Insulin from Glucose Sensing Insulin Derivatives." This invention features insulin derivatives equipped with a built-in glucose sensor, allowing for the controlled release of insulin based on glucose concentration in the surrounding medium.

Career Highlights

Throughout his career, Lauge Schaffer has worked with leading companies in the biopharmaceutical industry. Notably, he has been associated with Novo Nordisk A/S, a global leader in diabetes care, and Antyra Inc., where he has contributed to advancing innovative therapeutic solutions.

Collaborations

Lauge Schaffer has collaborated with esteemed professionals in his field, including Per Balschmidt and Thomas Hoeg-Jensen. These collaborations have further enriched his research and development efforts.

Conclusion

Lauge Schaffer is a distinguished inventor whose work in GLP-1 compounds and insulin derivatives has the potential to transform diabetes management. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…